On May 18, Skadden held a webinar titled “Antitrust Update for the Pharmaceutical Industry: Key Rulings, Cases To Watch and Recent Legislative Changes.” Skadden attorneys discussed competition law issues currently impacting the pharmaceutical industry in courts and legislatures, including restraints of trade and the continued vitality of FTC v. Actavis, pharmaceutical-based monopolization claims in the courts, class certification in direct purchaser cases, and the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019. Antitrust/competition partners Steven Sunshine, Karen Lent and Julia York spoke.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates